Dispensary Product Types: Flower, Edibles, Tinctures, Topicals, and More

Walk into a licensed dispensary for the first time and the menu can look like a foreign language — strains with evocative names, milligram counts, abbreviations like THC and CBD stacked next to product formats that range from the familiar to the genuinely unexpected. The cannabis product landscape has expanded dramatically since state-level legalization began, and every format delivers the plant's compounds through a different mechanism, at a different speed, for a different duration. Knowing what distinguishes flower from edibles, concentrates, or topicals matters practically — because the same compound at the same dose can behave entirely differently depending on how it enters the body.

Definition and scope

Cannabis dispensaries in licensed states sell products derived from the Cannabis sativa plant, with compounds — primarily delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD) — extracted, refined, or preserved across a wide range of delivery formats. The FDA classifies cannabidiol under certain regulatory frameworks distinct from state cannabis licensing, which means the regulatory picture involves both state cannabis control boards and, for some hemp-derived products, federal oversight.

State-level seed-to-sale tracking systems — most commonly METRC, used in over 30 states — assign a unique identifier to every cannabis product unit from cultivation through retail sale. The dispensary lab testing requirements that govern these products mandate that each batch be tested for potency, pesticides, residual solvents, microbials, and heavy metals before reaching the shelf. The product categories below represent the major format types found across licensed dispensaries nationally.

How it works

The mechanism behind any cannabis product is pharmacokinetic: how fast the compound reaches the bloodstream, at what peak concentration, and for how long. That timeline varies more than most consumers expect.

The major product types, ranked by onset speed:

1. Inhalable flower — Dried, cured cannabis bud, the oldest and most recognizable format. Combustion or vaporization delivers compounds to the lungs, where absorption into the bloodstream occurs within 90 seconds to 3 minutes. Effects typically peak within 10–30 minutes and last 1–3 hours. Dispensary flower products are sold by weight — typically in increments of 1 gram, 3.5 grams (an eighth), 7 grams (a quarter), or 28 grams (an ounce), subject to state purchase limits.

2. Vape cartridges and concentrates — Concentrated cannabis oil delivered via a battery-powered vaporizer, or high-potency extracts (wax, shatter, live resin, rosin) consumed through a dab rig. Onset is comparably fast to flower. Dispensary concentrates can test at 60–90% THC, versus flower's typical 15–30% range — a distinction with meaningful dosing implications.

3. Tinctures and sublingual sprays — Alcohol- or oil-based cannabis extracts applied under the tongue. Sublingual absorption bypasses first-pass liver metabolism, producing onset in roughly 15–45 minutes with effects lasting 2–4 hours. Dispensary topicals and tinctures are often preferred in medical contexts for their dose precision.

4. Edibles — Cannabis infused into food or beverage products: gummies, chocolates, beverages, capsules, mints. Oral ingestion routes THC through the digestive system and liver, where it converts to 11-hydroxy-THC — a metabolite with notably stronger and longer-lasting effects than inhaled THC. Onset ranges from 30 minutes to 2 hours; effects can persist 4–8 hours. Dispensary edibles are typically sold in 5 mg or 10 mg THC-per-serving increments under state product labeling rules.

5. Topicals — Creams, balms, patches, and lotions infused with cannabinoids, applied directly to skin. Standard topicals are non-systemic — they act locally without producing psychoactive effects. Transdermal patches, by contrast, are formulated to cross the skin barrier and enter the bloodstream.

6. CBD products — Products derived from hemp (federally defined as Cannabis sativa with less than 0.3% THC by dry weight under the 2018 Farm Bill) are sold both in dispensaries and in general retail. Dispensary CBD products typically carry higher quality assurance standards than gas station shelf alternatives, given state testing requirements.

Common scenarios

A patient managing chronic pain may rotate between a high-CBD tincture for daytime use and an indica-leaning flower product in the evening — keeping psychoactive effects low during working hours while leveraging longer-duration relief overnight. This is one reason dispensary dosing guidance has become a distinct competency for trained budtenders, separate from simple product knowledge.

Someone new to cannabis is most likely to have a problematic first experience with edibles — specifically, consuming a second dose before the first has taken effect, then encountering the delayed peak of both doses simultaneously. This is a known, documented risk pattern. The Colorado Retail Marijuana Public Health Advisory Committee has flagged edible overconsumption as a leading factor in cannabis-related emergency department visits in that state.

For cancer patients or others with nausea or swallowing difficulties, sublingual tinctures or vaporized flower may be more accessible formats than edibles. Dispensaries operating in medical cannabis markets often stock a broader tincture and capsule selection than recreational-only outlets.

Decision boundaries

The distinction between product types is not merely one of preference — it carries safety and regulatory weight.

Format matters for tolerance and dose control. Concentrates at 80% THC require significantly different dosing math than flower at 20% THC. State dispensary compliance requirements mandate that all products carry labeled potency, but interpreting that label correctly requires understanding the delivery format.

Topical versus transdermal is a functional distinction. A standard topical balm will not appear in a drug test; a transdermal patch delivering cannabinoids systemically can. Dispensary staff and product packaging should specify which category a given product falls into.

Medical versus recreational access shapes availability. Certain high-potency or high-dose formulations — 100 mg THC edibles, for instance — are restricted to medical cannabis patients in states like Massachusetts, while recreational purchasers are limited to 5 mg per serving and 100 mg per package. Understanding which type of dispensary carries which product tier is a practical prerequisite before visiting.